Brief: Jubilant Pharmova Says JBIRSPL To Acquire 80% Stake In Jasmin For Upto 4.4 Mln Euro
Oct 4 (Reuters) - Jubilant Pharmova Ltd JUBA.NS :
* JBIRSPL TO ACQUIRE 80% EQUITY CAPITAL IN JASMIN FOR UPTO
4.4
MILLION EURO
* JASMIN TO ACQUIRE PIERRE FABRE’S RESEARCH AND DEVELOPMENT
CENTRE
AT SAINT JULIEN, FRANCE
Source text for Eikon: ID:nNSE76LCtq
Further company coverage: JUBA.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Jubilant Pharmova
See all newsBrief: Jubilant Pharmova Sept-Quarter Consol Net Profit 312 Million Rupees
Brief: Jubilant Pharmova Says Jubilant Therapeutics Announces Oral Presentation Of Preliminary Phase 1 Clinical Data For JBI-802
India New Issue-Jubilant Pharmova to issue 3-year bonds, bankers say
India's Jubilant Pharmova eyes $150 mln through rupee debt sale, bankers say
Brief: Jubilant Pharmova To Consider Raising Of Funds Through Issuance Of Non- Convertible Debentures